Clinical Expert Commentaries - Response Assessment

Dr. Shaji Kumar defines clinical trial endpoints and how each endpoint is evaluated.
Clinical Expert Commentaries published on July 2, 2013 in Response Assessment
Sandra Kurtin discusses the management and risk reduction strategies associated with carfilzomib.
Clinical Expert Commentaries published on June 28, 2013 in Response Assessment
Sandra Kurtin discusses the management and risk reduction strategies associated with pomalidomide.
Clinical Expert Commentaries published on May 17, 2013 in Response Assessment
Sandra Kurtin discusses the administration of subcutaneous bortezomib.

Results 1 - 4 of 4